Shaoqiang Lin

Shaoqiang Lin

Auto-generated profile, based on publicly available information

Shaoqiang Lin

Joint Institute of Metabolic Medicine Between State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong and Jinan University, Guangzhou, China; Central Laboratory of the First Affiliated Hospital of Jinan University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Hepatology
Verified
Journal Article
Closed access
DYDewei Ye
Dewei Ye
KYKangmin Yang
Kangmin Yang
SZShufei Zang
Shufei Zang
ZLZhuofeng Lin
Zhuofeng Lin
HCHau-Tak Chau
Hau-Tak Chau
YWYu Wang
Yu Wang

1 April 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HLHaiyingjie Lin
Haiyingjie Lin
XCXiaoting Chen
Xiaoting Chen
CZChengyong Zhang
Chengyong Zhang
TYTingting Yang
Tingting Yang
ZDZhendong Deng
Zhendong Deng
DJDadi Jin
Dadi Jin
EF24, a synthetic analogue of curcumin, was developed as an anti-tumor compound to induce apoptosis, inhibit proliferation and metastasis in various cancers. However, whether EF24 induces ferroptosis in osteosarcoma cells or not, and its underlying mechanism remains largely elusive. After EF24 combining with or without other compounds treatments, mRNA expression profiles were proceeded by RNA sequencing. Cytotoxicity was measured by cell counting kit-8 assay. Cell death was quantified by flow cytometer. Gene expression was quantified by real-time PCR. Protein level was detected by western blot. Malonydialdehyde (MDA) level was measured by lipid peroxidation MDA assay kit. Reactive oxygen species (ROS) level was measured by ROS Assay Kit. Ferric ion was measured by Iron Assay kit. EF24 significantly induced cell death in osteosarcoma cell lines, and this effect was significantly reversed by ferrostatin-1, but not Z-VAD(Ome)-FMK, MRT68921 or necrosulfonamide. EF24 significantly increased MDA level, ROS level and intracellular ferric ion level, these effects were significantly attenuated by ferrostatin-1. EF24 upregulated HMOX1 expression in a dose dependent manner, overexpression of HMOX1 facilitated EF24 to induce ferroptosis in osteosarcoma cell lines. HMOX1 knockdown attenuated EF24-induced cytotoxicity and attenuated EF24-induced inhibition of Glutathione Peroxidase 4 (GPX4) expression. Our results showed that EF24 upregulated HMOX1 to suppress GPX4 expression to induce ferroptosis by increasing MDA level, ROS level and intracellular ferric ion level. Thus, EF24 might serve as a potential agent for the treatment of HMOX1-positive osteosarcoma patients.

1 March 2019 in Reproductive Sciences
Verified
Journal Article
Closed access
LGLufen Gao
Lufen Gao
ZHZhongwei Huang
Zhongwei Huang
HLHaiyingjie Lin
Haiyingjie Lin
YTYuke Tian
Yuke Tian
PLPing Li
Ping Li
SLShaoqiang Lin
Shaoqiang Lin

1 January 2014 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
ZLZhenzhen Lian
Zhenzhen Lian
XYXiaojing Yin
Xiaojing Yin
HLHua Li
Hua Li
LJLili Jia
Lili Jia
XHXiuzhen He
Xiuzhen He
SLShaoqiang Lin
Shaoqiang Lin
Lian Z, et al. Ann Dermatol. 2014 Feb;26(1):1-10. https://doi.org/10.5021/ad.2014.26.1.1

21 October 2021 in Diabetes
Verified
Journal Article
Closed access
PDF file
WSWei Sun
Wei Sun
TNTao Nie
Tao Nie
KLKuai Li
Kuai Li
WWWenjie Wu
Wenjie Wu
QLQiaoyun Long
Qiaoyun Long
HXHui Hannah Xiaoyan
Hui Hannah Xiaoyan
Background & Aims Hepatosteatosis, defined as excessive intrahepatic lipid accumulation, represents the first step of NAFLD. When combined with additional cellular stress, this benign status progresses to local and systemic pathological conditions such as NASH and insulin resistance. However, the molecular events directly caused by hepatic lipid build-up, in terms of its impact on liver biology and peripheral organs, remain unclear. Carnitine palmitoyltransferase 1A (CPT1A) is the rate limiting enzyme for long chain fatty acid beta-oxidation in the liver. Here we utilise hepatocyte-specific Cpt1a knockout (LKO) mice to investigate the physiological consequences of abolishing hepatic long chain fatty acid metabolism. Approach & Results Compared to the wild-type (WT) littermates, high fat diet (HFD)-fed LKO mice displayed more severe hepatosteatosis but were otherwise protected against diet-induced weight gain, insulin resistance, hepatic ER stress, inflammation and damage. Interestingly, increased energy expenditure was observed in LKO mice, accompanied by enhanced adipose tissue browning. RNAseq analysis revealed that the peroxisome proliferator activator alpha (PPARα)- fibroblast growth factor 21 (FGF21) axis was activated in liver of LKO mice. Importantly, antibody-mediated neutralization of FGF21 abolished the healthier metabolic phenotype and adipose browning in LKO mice, indicating that the elevation of FGF21 contributes to the improved liver pathology and adipose browning in HFD-treated LKO mice. Conclusions Liver with deficient CPT1A expression adopts a healthy steatotic status that protects against HFD-evoked liver damage and potentiates adipose browning in an FGF21-dependent manner. Inhibition of hepatic CPT1A may serve as a viable strategy for the treatment of obesity and NAFLD.

1 May 2019 in Life Sciences
Verified
Journal Article
Closed access
JLJinyuan Li
Jinyuan Li
QCQiufang Chen
Qiufang Chen
ZDZhendong Deng
Zhendong Deng
XCXiaoting Chen
Xiaoting Chen
HLHong Liu
Hong Liu
NLNaihua Liu
Naihua Liu